Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies

被引:22
作者
Schmith, V. D. [1 ]
Foss, J. F. [2 ]
机构
[1] GlaxoSmithKline, Dept Clin Pharmacol Modeling & Simulat, Res Triangle Pk, NC 27709 USA
[2] Cleveland Clin, Dept Gen Anesthesiol, Cleveland, OH 44106 USA
关键词
DRUG-DISEASE INTERACTIONS; RHEUMATOID-ARTHRITIS; METABOLIZING-ENZYMES; PHARMACOKINETICS; TRANSPORTERS; PROPRANOLOL; PHARMACODYNAMICS; DISPOSITION; EXPRESSION; MEDIATORS;
D O I
10.1038/clpt.2009.258
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The impact of inflammation on variability in the pharmacokinetics (PK) and pharmacodynamics (PD) of drugs should be considered in the design, analysis, and interpretation of clinical pharmacology studies. Data suggest that the metabolism and transport of drugs, as well as the expression of receptors, may change in the presence of inflammation. The clinical implications of these changes are not straightforward; they may vary depending on whether the inflammation is active or controlled and may change with time and successful treatment of the inflammation.
引用
收藏
页码:488 / 491
页数:4
相关论文
共 50 条
[21]   Preclinical pharmacokinetics, disposition, and translational pharmacokinetic/pharmacodynamic modeling of savolitinib, a novel selective cMet inhibitor [J].
Gu, Yi ;
Sai, Yang ;
Wang, Jian ;
Yu, Meijing ;
Wang, Guanglin ;
Zhang, Li ;
Ren, Hongcan ;
Fan, Shiming ;
Ren, Yongxin ;
Qing, Weiguo ;
Su, Weiguo .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 136
[22]   Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats [J].
Hu, Yingfan ;
Wang, Li ;
Xiang, Li ;
Wu, Jiasi ;
Huang, Wen'ge ;
Xu, Chensi ;
Meng, Xianli ;
Wang, Ping .
SCIENTIFIC REPORTS, 2019, 9 (1)
[23]   Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment [J].
Wirth, Fernanda ;
Staudt, Keli J. ;
Araujo, Bibiana, V ;
Ishida, Kelly .
FUTURE MICROBIOLOGY, 2022, 17 (12) :969-982
[24]   Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment [J].
Tfelt-Hansen, P. ;
Edvinsson, L. .
CEPHALALGIA, 2007, 27 (10) :1091-1093
[25]   Open Source Pharmacokinetic/Pharmacodynamic Framework: Tutorial on the BioGears Engine [J].
McDaniel, Matthew ;
Carter, Jennifer ;
Keller, Jonathan M. ;
White, Steven A. ;
Baird, Austin .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (01) :12-25
[26]   Pharmacokinetic and pharmacodynamic studies on interaction of "Trikatu" with diclofenac sodium [J].
Lala, LG ;
D'Mello, PM ;
Naik, SR .
JOURNAL OF ETHNOPHARMACOLOGY, 2004, 91 (2-3) :277-280
[27]   Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats [J].
Stefkova-Mazochova, Kristyna ;
Danda, Hynek ;
Dehaen, Wim ;
Jurasek, Bronislav ;
Sichova, Klara ;
Pinterova-Leca, Nikola ;
Mazoch, Vladimir ;
Krausova, Barbora Hrcka ;
Kysilov, Bohdan o ;
Smejkalova, Tereza ;
Vyklicky, Ladislav ;
Kohout, Michal ;
Hajkova, Katerina ;
Svozil, Daniel ;
Horsley, Rachel R. ;
Kuchar, Martin ;
Palenicek, Tomas .
BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (01) :65-83
[28]   Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys [J].
Cheng, Z ;
McKellar, Q ;
Nolan, A ;
Lees, P .
VETERINARY RESEARCH COMMUNICATIONS, 1996, 20 (05) :469-472
[29]   The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies [J].
Gaussem, P ;
Reny, JL ;
Thalamas, C ;
Chatelain, N ;
Kroumova, M ;
Jude, B ;
Boneu, B ;
Fiessinger, AN .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) :1437-1445
[30]   PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH A NEW ANXIOLYTIC, SURICLONE, UTILIZING EEG MAPPING AND PSYCHOMETRY [J].
SALETU, B ;
GRUNBERGER, J ;
LINZMAYER, L ;
SEMLITSCH, HV ;
ANDERER, P ;
CHWATAL, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (02) :145-156